Trial Profile
Phase 1 study of sangivamycin
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 Aug 2021
Price :
$35
*
At a glance
- Drugs Sangivamycin (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 17 Aug 2021 New trial record